Correlation Between Biztech Konsulting and Medicofarma Biotech

Can any of the company-specific risk be diversified away by investing in both Biztech Konsulting and Medicofarma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biztech Konsulting and Medicofarma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biztech Konsulting SA and Medicofarma Biotech SA, you can compare the effects of market volatilities on Biztech Konsulting and Medicofarma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biztech Konsulting with a short position of Medicofarma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biztech Konsulting and Medicofarma Biotech.

Diversification Opportunities for Biztech Konsulting and Medicofarma Biotech

-0.59

Correlation Coefficient

Biztech Konsulting  Medicofarma Biotech

Excellent diversification

The 3 months correlation between Biztech and Medicofarma is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Biztech Konsulting SA and Medicofarma Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicofarma Biotech and Biztech Konsulting is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biztech Konsulting SA are associated (or correlated) with Medicofarma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicofarma Biotech has no effect on the direction of Biztech Konsulting i.e., Biztech Konsulting and Medicofarma Biotech go up and down completely randomly.

Pair Corralation between Biztech Konsulting and Medicofarma Biotech

Assuming the 90 days trading horizon Biztech Konsulting SA is expected to generate 1.24 times more return on investment than Medicofarma Biotech. However, Biztech Konsulting is 1.24 times more volatile than Medicofarma Biotech SA. It trades about 0.11 of its potential returns per unit of risk. Medicofarma Biotech SA is currently generating about -0.06 per unit of risk. If you would invest  14.00  in Biztech Konsulting SA on October 12, 2024 and sell it today you would earn a total of  4.00  from holding Biztech Konsulting SA or generate 28.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	94.74%
Values	Daily Returns

Biztech Konsulting SA  vs.  Medicofarma Biotech SA

Biztech Konsulting

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Biztech Konsulting SA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Biztech Konsulting reported solid returns over the last few months and may actually be approaching a breakup point.

Medicofarma Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Biztech Konsulting and Medicofarma Biotech

The main advantage of trading using opposite Biztech Konsulting and Medicofarma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biztech Konsulting position performs unexpectedly, Medicofarma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicofarma Biotech will offset losses from the drop in Medicofarma Biotech's long position.

The idea behind Biztech Konsulting SA and Medicofarma Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.